Strathprints Home | Open Access | Browse | Search | User area | Copyright | Help | Library Home | SUPrimo

Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death

Tennant, D.A. and Frezza, C. and MacKenzie, E.D. and Nguyen, Q.D. and Zheng, L. and Selak, M.A. and Roberts, D.L. and Dive, C. (2009) Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death. Oncogene, 28 (45). pp. 4009-4021. ISSN 0950-9232

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

Cells exposed to low-oxygen conditions (hypoxia) alter their metabolism to survive. This response, although vital during development and high-altitude survival, is now known to be a major factor in the selection of cells with a transformed metabolic phenotype during tumorigenesis. It is thought that hypoxia-selected cells have increased invasive capacity and resistance to both chemo- and radiotherapies, and therefore represent an attractive target for antitumor therapy. Hypoxia inducible factors (HIFs) are responsible for the majority of gene expression changes under hypoxia, and are themselves controlled by the oxygen-sensing HIF prolyl hydroxylases (PHDs). It was previously shown that mutations in succinate dehydrogenase lead to the inactivation PHDs under normoxic conditions, which can be overcome by treatment with α-ketoglutarate derivatives. Given that solid tumors contain large regions of hypoxia, the reactivation of PHDs in these conditions could induce metabolic catastrophe and therefore prove an effective antitumor therapy. In this report we demonstrate that derivatized α-ketoglutarate can be used as a strategy for maintaining PHD activity under hypoxia. By increasing intracellular α-ketoglutarate and activating PHDs we trigger PHD-dependent reversal of HIF1 activation, and PHD-dependent hypoxic cell death. We also show that derivatized α-ketoglutarate can permeate multiple layers of cells, reducing HIF1α levels and its target genes in vivo.

Item type: Article
ID code: 26110
Notes: Strathprints' policy is to record up to 8 authors per publication, plus any additional authors based at the University of Strathclyde. More authors may be listed on the official publication than appear in the Strathprints' record.
Keywords: cancer, metabolism, prolyl hydroxylase, hypoxia, α-ketoglutarate, HIF, Neoplasms. Tumors. Oncology (including Cancer), Genetics, Molecular Biology, Cancer Research
Subjects: Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)
Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Related URLs:
    Depositing user: Strathprints Administrator
    Date Deposited: 08 Sep 2010 11:26
    Last modified: 05 Sep 2014 05:35
    URI: http://strathprints.strath.ac.uk/id/eprint/26110

    Actions (login required)

    View Item